
CAS 98902-29-5
:Formel:C19H24ClN5O4
InChl:InChI=1S/C19H23N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h4,6,9-11H,5,7-8H2,1-3H3,(H,21,25)(H2,20,22,23);1H
InChI Key:LYASKMMJFCEPIG-UHFFFAOYSA-N
SMILES:CN(CCCNC(=O)C1=CC=CO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
9 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochlorideFormel:C19H24ClN5O4Reinheit:95%Molekulargewicht:421.89N-[3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl]furan-2-carboxamide Hydrochloride
CAS:Formel:C19H23N5O4·ClHFarbe und Form:NeatMolekulargewicht:421.88N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:Formel:C19H24ClN5O4Reinheit:95%Farbe und Form:SolidMolekulargewicht:421.87802,3,4,5-Tetradehydro Alfuzosin Hydrochloride
CAS:Impurity Alfuzosin EP Impurity A / Alfuzosin USP Related Compound A
Stability Hygroscopic
Applications 2,3,4,5-Tetradehydro Alfuzosin Hydrochloride (Alfuzosin EP Impurity A) is an impurity of Alfuzosin (A532010) . Alfuzosin (A532010) is an α1-adrenoceptor antagonist with antihypertensive activity.
References Manoury, P.M. et al.: J. Med. Chem., 29, 19 (1986);Formel:C19H23N5O4·ClHFarbe und Form:NeatMolekulargewicht:421.88N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochlorideFormel:C19H24ClN5O4Reinheit:95%Molekulargewicht:421.88N-(3-((4-Amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)furan-2-carboxamide hydrochloride
CAS:Reinheit:95%Molekulargewicht:421.88000492,3,4,5-Tetradehydro alfuzosin hydrochloride
CAS:Alfuzosin is a potent, selective, and long-acting α1A-adrenergic receptor antagonist. It is used to treat benign prostatic hyperplasia (BPH) in males. Alfuzosin is also used as an antihypertensive agent, for the treatment of pheochromocytoma, and for the treatment of benign prostatic hyperplasia in males. The hydrogenation of 2,3,4,5-tetradehydroalfuzosin to alfuzosin hydrochloride is performed by liquid hydrogenation or by hydrogenation on a palladium catalyst in a mixture of dimethylformamide and hexamethylphosphoramide. This process minimizes the formation of impurities such as 2,3,4-trimethoxy alfuzosin.Formel:C19H24ClN5O4Reinheit:Min. 95%Farbe und Form:White PowderMolekulargewicht:421.88 g/mol








